Rating History for ARIAD Pharmaceuticals (ARIA) by Barclays
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/10/2017 | N/A | Upgrade | Equalweight (Underweight) |
24.00 (9.00) |
13.74 (23.99) |
74.6% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/10/2017 | N/A | Upgrade | Equalweight (Underweight) |
24.00 (9.00) |
13.74 (23.99) |
74.6% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||